tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Savara present results from Phase 3 IMPALA-2 Molgramostim study

Savara (SVRA) “announced the acceptance of two abstracts for poster presentation and one abstract as an oral presentation at CHEST 2025 in Chicago, Illinois, October 19-22. The Company will also host a Learning Theatre titled “Advances in Autoimmune Pulmonary Alveolar Proteinosis” at the meeting which is open to all registered conference attendees.”

TipRanks Cyber Monday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1